Hello all, does anybody know if there is anything new coming out for non brca people for ovarian cancer. Niraparib stopped working the carbo has kept the tumors stable but they have not shrunk, the ca125 is coming down though which is good but when the carbo has finished the cancer will probably grow again as niraparib has been tried they won’t give another parb inhibitor really worried 😟 any information would really be appreciated . My mum can only have carbo platin as she has a fast heart beat.
Thank you best wishes Ali xxx
Written by
Aliollie
To view profiles and participate in discussions please or .
Hi, don’t know where you are located but at msk they are retesting tumors to see if you have a bcra like gene - not sure exactly what the gene is. But this opens the doors for new treatments, I will see if more information is available
I am in the USA, and my genetic test in 2017 showed no mutation in either BRCA gene, but there was a mutation in the PALB2 gene. The PALB2 gene was a mystery at the time, and I was told it was a newly "discovered" gene mutation that they had little information about.
What is interesting is that the PALB2 gene is thought to be the trigger to turn on the BRCA2 gene that controls tumor growth. So, if a PALB2 gene (trigger) is defective, but the BRCA2 gene is not, what are they missing? PALB2 gene is directly linked to BRCA2, so why are there no studies to include this genetic defect's response to any drugs?
The medical research seems to be totally focused on the BRCA "sisters", when there is obviously more to ovarian cancer than that. I have gone through all chemo protocols, yet the cancer is growing again, even though I'm not even finished with the avastin/carboplatin/doxorubicin regimen.
My doctor ordered molecular studies on the cancer removed from the latest surgery, and it didn't find any effective treatments. It listed hormone blockers or Keytruda as a last resort, but with limited chance of success. So my options are also very limited, and I'm losing hope.
Your question about treatments for non-BRCA ovarian patients is a great one for clinical trials. I hope they will expand their thinking on this issue. I'm sure there are many others who have perfectly fine BRCA genes, but still have advanced ovarian cancer.
I too am brace negative I am in San Diego and fear the worst as the cancer responded well with Carbo Taxol .....Avastin was added then numbers started to rise 6 months later. instead of Pet Scan they did CT scan showed normal despite my pleas....pet scan last month after a year of Avastin showed active cancer in blood and lymph nodes. After biopsy to see if cancer has mutated put on Doxil and Carbo..........I fear the worst as you are right there doesn't seem to be the excitement to find a parp inhibitor for "our" non braca issues. Any one know of ANY studies/trials being conducted in the United States for us???
Thanks for your replies really sorry your in the same position I don’t know if this may help you both there is care oncology london and one in America that may be useful. Let’s hope that somebody replies on here with some good news love Ali xx
Keytruda works as maintenance for a lot of people although it would be off label I believe, also Clinical Trials. Immunotherapy tends to be a level playing field where you don't need to be BRACA sensitive also your Onc will know about other hormone based drugs. It's a matter of finding the magic bullet. All the very best Sue xx
Hi Supermary, I asked my oncologist about a pathology report on my tumours because I was interested in the ENHERTU trial but I didn’t really get a definitive answer.I don’t think he knew if they had or hadn’t got a pathology report. I didn’t delve too deeply as I thought I may have asked the wrong question so I still don’t know
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.